Applicant, as named in the Orange Book
Ucb Inc
Part of UCB
Company and ticker: cliffwatch mapping, checked against SEC EDGAR
Next listed expiry: Nayzilam on 18 Jan 2028. 8 products with live protection, 7 without.
Products with listed protection
| Drug | Earliest generic entry |
|---|---|
| Nayzilam NDA 211321 midazolam | 18 Jan 2028 patent |
| Keppra Xr NDA 022285 · 2 strengths levetiracetam | 17 Sep 2028 patent |
| Briviact NDA 205836 · 5 strengths brivaracetam | 9 Apr 2030 patent |
| Keppra NDA 021035 · 4 strengths levetiracetam | 7 Dec 2031 patent |
| Neupro NDA 021829 · 6 strengths rotigotine | 1 Mar 2032 patent |
| Zilbrysq NDA 216834 · 3 strengths zilucoplan sodium | 12 Jun 2035 patent |
| Fintepla NDA 212102 fenfluramine hydrochloride | 29 Dec 2038 patent |
| Kygevvi NDA 219792 doxecitine; doxribtimine | 19 Aug 2040 patent |
Recent events
- Briviact · Generic approved · ANDA 220164, LupinApproved 23 Feb 2026Detected 25 Oct 2026
- Keppra · Generic approved · ANDA 218080, AdaptisApproved 21 Nov 2025Detected 25 Oct 2026
- Briviact · Generic approved · ANDA 220136, Zhejiang Jutai PharmApproved 8 Sep 2026Detected 25 Oct 2026
- Briviact · Generic approved · ANDA 218494, Zhejiang Poly PharmApproved 23 Feb 2026Detected 25 Oct 2026
- Vimpat · Generic approved · ANDA 217596, Prod DevelopmentApproved 15 Jun 2026Detected 25 Oct 2026
- Briviact · Generic approved · ANDA 221301, Zydus LifesciencesApproved 20 Oct 2026Detected 25 Oct 2026
- Keppra · Generic approved · ANDA 215465, KnackApproved 2 Dec 2025Detected 25 Oct 2026
- Briviact · Generic approved · ANDA 219952, Sciegen PharmsApproved 1 Jul 2026Detected 25 Oct 2026
- Keppra · Generic approved · ANDA 218364, Mylan Labs LtdApproved 8 May 2026Detected 25 Oct 2026
- Briviact · First generic approved · ANDA 214924, MsnApproved 23 Feb 2026Detected 25 Oct 2026
- Briviact · Generic approved · ANDA 214924, MsnApproved 23 Feb 2026Detected 25 Oct 2026
- Keppra · Generic approved · ANDA 208458, Baxter Hlthcare CorpApproved 6 Aug 2026Detected 25 Oct 2026
- Briviact · Generic approved · ANDA 214921, MsnApproved 13 Nov 2025Detected 25 Oct 2026
- Briviact · First generic approved · ANDA 214922, MsnApproved 19 Feb 2026Detected 25 Oct 2026
- Briviact · Generic approved · ANDA 214922, MsnApproved 19 Feb 2026Detected 25 Oct 2026
- Briviact · Generic approved · ANDA 220470, BreckenridgeApproved 23 Feb 2026Detected 25 Oct 2026
- Briviact · Generic approved · ANDA 219766, ShandongApproved 13 Jul 2026Detected 25 Oct 2026
- Briviact · Generic approved · ANDA 219772, Alkem Labs LtdApproved 23 Feb 2026Detected 25 Oct 2026
- Briviact · First generic approved · ANDA 214880, Micro LabsApproved 23 Feb 2026Detected 25 Oct 2026
- Briviact · Generic approved · ANDA 214880, Micro LabsApproved 23 Feb 2026Detected 25 Oct 2026
- Briviact · Generic approved · ANDA 214875, ApotexApproved 23 Feb 2026Detected 25 Oct 2026
- Briviact · First generic approved · ANDA 218249, Hainan PolyApproved 23 Feb 2026Detected 25 Oct 2026
- Briviact · Generic approved · ANDA 218249, Hainan PolyApproved 23 Feb 2026Detected 25 Oct 2026
- Briviact · Generic approved · ANDA 220385, Regcon HoldingsApproved 23 Feb 2026Detected 25 Oct 2026
- Vimpat · Generic approved · ANDA 220386, Regcon HoldingsApproved 29 Jan 2026Detected 25 Oct 2026
- Vimpat · Generic approved · ANDA 220366, AdaptisApproved 21 May 2026Detected 25 Oct 2026
- Briviact · Generic approved · ANDA 220288, Aurobindo PharmaApproved 10 Aug 2026Detected 25 Oct 2026
- Vimpat · Generic approved · ANDA 220268, Glenmark PharmsApproved 21 Jan 2026Detected 25 Oct 2026
Products without listed protection (7)
| Drug | Earliest generic entry |
|---|---|
| Briviact NDA 205838 brivaracetam | open now no listed protection |
| Briviact NDA 205837 brivaracetam | open now no listed protection |
| Keppra NDA 021505 levetiracetam | open now no listed protection |
| Keppra NDA 021872 levetiracetam | open now no listed protection |
| Vimpat NDA 022254 lacosamide | open now no listed protection |
| Vimpat NDA 022255 lacosamide | open now no listed protection |
| Vimpat NDA 022253 · 4 strengths lacosamide | open now no listed protection |